Green Alpha Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Buy
+8,372
New +$219K 0.22% 83
2026
Q1
Sell
-10,153
Closed -$166K 114
2025
Q4
$166K Sell
10,153
-11,115
-52% -$168K 0.15% 103
2025
Q3
$249K Sell
21,268
-1,188
-5% -$15.5K 0.24% 84
2025
Q2
$260K Sell
22,456
-1,514
-6% -$13.8K 0.25% 87
2025
Q1
$209K Sell
23,970
-757
-3% -$9.54K 0.22% 95
2024
Q4
$355K Buy
+24,727
New +$390K 0.28% 106
2024
Q2
Sell
-5,713
Closed -$214K 142
2024
Q1
$214K Buy
5,713
+60
+1% +$2.64K 0.16% 130
2023
Q4
$316K Sell
5,653
-2,834
-33% -$123K 0.23% 129
2023
Q3
$350K Sell
8,487
-2,311
-21% -$120K 0.27% 117
2023
Q2
$603K Buy
10,798
+436
+4% +$23.6K 0.4% 98
2023
Q1
$578K Sell
10,362
-345
-3% -$16.1K 0.41% 96
2022
Q4
$390K Buy
10,707
+890
+9% +$29.1K 0.32% 109
2022
Q3
$280K Sell
9,817
-1,676
-15% -$63.9K 0.24% 128
2022
Q2
$520K Buy
11,493
+3,492
+44% +$181K 0.12% 126
2022
Q1
$609K Buy
8,001
+1,049
+15% +$91.8K 0.41% 101
2021
Q4
$1.04M Buy
6,952
+664
+11% +$102K 0.7% 69
2021
Q3
$915K Buy
6,288
+863
+16% +$148K 0.63% 82
2021
Q2
$1.06M Buy
5,425
+3,977
+275% +$720K 0.72% 59
2021
Q1
$262K Buy
+1,448
New +$250K 0.26% 103

Other funds holding TXG

Green Alpha Advisors's TXG Position: Q2 2026 in Review

Green Alpha Advisors opened a new position in 10x Genomics (TXG) in Q2 2026: 8,372 shares worth $321K. The stake represents 0.22% of the portfolio and ranks #83 among its holdings. This is a return to the name: Green Alpha Advisors previously reported a position in TXG as recently as Q4 2025.

Green Alpha Advisors first reported a position in TXG in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.06M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Green Alpha Advisors held 8,372 shares of 10x Genomics worth $321K as of Q2 2026.
  • 10x Genomics was a new Green Alpha Advisors position in Q2 2026.
  • 10x Genomics made up 0.22% of Green Alpha Advisors's portfolio in Q2 2026, its #83 holding.
  • Green Alpha Advisors first reported a position in 10x Genomics in Q1 2021 and has held it in 19 quarters since.
  • Green Alpha Advisors's 10x Genomics position peaked at $1.06M in Q2 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.